glp-1/gip/glucagon triple agonist name Dual and Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data The Effects of Dual GLP-1/GIP

What it does, if you are deficient, is fix the energy and metabolic drag that low B12 causes

When released (e.g., with vesicle depletion by reserpine or amphetamine) [69,70,152] it can substitute disturbed dopamine (i.e., shortage (reserpine) [69] or excess (amphetamine) [70]) as competing successfully for sites at dopamine receptors (i.e., counteracting the adverse effects of both dopamine agonists [70,152,153] and dopamine antagonists [68,70,152])

Dihexa Side Effects & Safety There is limited clinical data available on the side effects of Dihexa, as it is still under research and not widely used in clinical settings

Ikeno H, Tochio T, Tanaka H, Nakata S

Some patients respond better to one GLP-1 drug than another due to genetic variation in GLP1R gene expression or differences in how their bodies metabolize each compound